Psychological and Clinical Factors That Predict Intent to Deprescribe Medications Among Older Adults
調査の概要
詳細な説明
Around one-half of older adults take one or more medications that are inappropriate or medically unnecessary. These medications can cause side effects that are unacceptable to patients. Several studies provide guidance to clinicians about the process of stopping specific types of medications (e.g., steps that clinicians can take to reduce and stop a medication for anxiety or difficulty sleeping). However, these approaches are not always successful. A critical gap with these approaches is they tend to focus on the medication, rather than the patient, and their individual needs.
Our research team seeks to learn more about factors that are important to patients when they consider reducing or stopping a medication. The investigators will do this by conducting two surveys each with 4,800 older adults across four countries (United States, United Kingdom, Netherlands, and Australia). Each participant will be asked to give their opinions on a hypothetical patient scenario that has been developed by our diverse team in partnership with our stakeholder organizations. In the first survey, the investigators will examine how the reason for using the medication (e.g. preventing a disease or treating symptoms of a disease) as well as the reason for a recommendation to stop the medication (e.g. lack of benefit vs. potential for harm) influence older adults' willingness to stop medications. In the second survey, the investigators will examine how different social and clinical factors and whether the participant is making a recommendation about oneself (as if they were the patient in the case) or on behalf of the patient in the case (e.g., if it was their friend) influence their willingness to stop medications. The investigators will work with Qualtrics, an international company that distributes surveys, to collect this data that does not include any identifying information.
The investigators anticipate that once the survey is designed and show that it is successful for studying patient perspectives about stopping medicines, it can then apply the same study approach to test the effect of other relevant factor that may influence the decision to stop or reduce a medication. The investigators anticipate that our research will significantly contribute to our understanding of how older adults make decisions about stopping medications. This information will be helpful to researchers and clinicians to ensure future services can be developed to best support patients to make decisions about stopping or reducing inappropriate or unnecessary medication.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Michigan
-
Ann Arbor、Michigan、アメリカ、48109
- University of Michigan
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- 65 years and older
- Resides in a participating country
Exclusion Criteria:
- None
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:ケースのみ
- 時間の展望:断面図
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Survey 1 Statin - May cause harm
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin as it may be causing harm.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 1 Stain - May lack benefit
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin as it may lack benefit.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 1 Statin - May cause harm and lack benefit
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin as it may be causing harm and lack benefit.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 1 PPI - May cause harm
Participants in this arm will be exposed to a scenario in which a patient takes a proton pump inhibitor (heartburn) medication.
The primary care provider raises the idea of stopping the PPI as it may be causing harm.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 1 PPI - May lack benefit
Participants in this arm will be exposed to a scenario in which a patient takes a proton pump inhibitor (heartburn) medication.
The primary care provider raises the idea of stopping the PPI as it may lack benefit.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 1 PPI - May cause harm and lack benefit
Participants in this arm will be exposed to a scenario in which a patient takes a proton pump inhibitor (heartburn) medication.
The primary care provider raises the idea of stopping the PPI as it may be causing harm and lack benefit.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 2 Statin - May cause harm and lack benefit
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin as it may be causing harm and lack benefit.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 2 Statin - Cardiologist
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin previously started by a cardiologist.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 2 Statin - Daughter Preference
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin but the patient's adult daughter prefers for her to continue the medication.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 2 Statin - Husband Stroke
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin but the patient's husband previously had a stroke after he stopped his statin.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 2 Statin - Flier
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin but the patient saw an educational flier about strokes in the waiting room.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
|
Survey 2 Statin - Difficulty Maintaining Lifestyle Changes
Participants in this arm will be exposed to a scenario in which a patient takes a statin (cholesterol) medication.
The primary care provider raises the idea of stopping the statin but the patient recognizes that they have had difficulty exercising and eating healthier foods.
|
Participants will be randomized to one of the arms.
Each arm will contain a different hypothetical scenario.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Response to question statement "I think that Mrs. EF should follow her PCPs recommendation and stop taking simvastatin."
時間枠:1 year
|
Level of agreement with the primary care provider's recommendation to stop the medication presented in the hypothetical scenario (1=strongly disagree, 6=strongly agree)
|
1 year
|
協力者と研究者
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- HUM00183129
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。